Partnership Strategy NovAliX has established strategic partnerships with renowned institutions like Max Planck and companies like Bruker, indicating a focus on collaboration and innovation. Leveraging these partnerships can open doors for joint research projects and joint offerings to a wider customer base.
Acquisition of Assets Through the acquisition of Galapagos' drug discovery and research operations, NovAliX has expanded its capabilities and assets. This presents opportunities to upsell services and expertise to existing and new clients, showcasing a broader range of solutions.
Technological Advancements With a tech stack including WordPress, Apache, and other modern tools, NovAliX demonstrates a commitment to staying technologically advanced. Highlighting these tech capabilities in sales pitches can appeal to tech-savvy clients seeking innovative solutions in drug discovery.
Diverse Therapeutic Areas NovAliX's presence in diverse therapeutic areas such as oncology, inflammation, and infectious diseases provides a wide market reach. Tailoring sales strategies to showcase expertise in each area can attract clients looking for specialized solutions in specific medical fields.
Revenue Sector With reported revenues in the range of $50M - 100M, NovAliX falls within the mid-size revenue bracket, indicating financial stability and growth potential. This financial health can be leveraged during sales discussions to instill confidence in clients about long-term partnerships.
21
$10M
10K$1B
1K
106$10M$50M
1K$100M$1B
51$10M$50M
198$10M$50M
1K$100M$1BNovalix uses 8 technology products and services including MySQL, Slick, Microsoft, and more. Explore Novalix's tech stack below.
| Novalix Email Formats | Percentage |
| FLast@novalix.com | 85% |
| LFirst@novalix.com | 10% |
| FL@novalix.com | 3% |
| FMiddleLast@novalix.com | 2% |
Pharmaceutical ManufacturingGrand Est, France201-500 Employees
Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com
Company Overview
Media & News
Funding & FinancialsNovalix's revenue is in the range of $50M$100M
Funding & FinancialsNovalix's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com